Pyxis Oncology: Funding, Investors & Team (Oct 2026)
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.
Pyxis Oncology has raised $50.0M across 1 funding round on record, the most recent an undisclosed round of $50.0M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pyxis Oncology Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Pyxis Oncology Funding Rounds
Pyxis Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Pyxis Oncology Funding Compared to Other Biotechnology Startups
Pyxis Oncology's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pyxis Oncology in Biotechnology and Boston
Companies Similar to Pyxis Oncology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Pyxis Oncology Funding FAQs
What does Pyxis Oncology do?
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.
How much funding has Pyxis Oncology raised?
Pyxis Oncology has raised $50.0M across 1 round on record. The most recent is an undisclosed round of $50.0M announced in Jun 2026.
When did Pyxis Oncology last raise funding?
Pyxis Oncology's most recent funding round on record is an undisclosed round of $50.0M, announced in Jun 2026.
Who founded Pyxis Oncology?
FundedIQ lists Lara S (Founder) at Pyxis Oncology.
Where is Pyxis Oncology headquartered?
Pyxis Oncology is based in Boston, Massachusetts, United States.
How many employees does Pyxis Oncology have?
Pyxis Oncology is in the 11-50 employee band.
How does Pyxis Oncology's funding compare to other Biotechnology startups?
Pyxis Oncology's latest round of $50.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pyxis Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pyxis Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.